NCT01660373View on ClinicalTrials.gov

Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome

PHASE3UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Non-ST Segment Elevation Acute Coronary Syndrome
Interventions
DRUG

Tirofiban

0.4ug/kg/min for 30min followed by 0.1ug/kg/min

DRUG

Ticagrelor

loading dose(180mg) followed by maintenance dose(90mg bid)

Trial Locations (1)

626-770

RECRUITING

Pusan National University Yangsan Hospital, Yangsan

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Pusan National University Yangsan Hospital

OTHER

NCT01660373 - Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter